Your browser doesn't support javascript.
loading
Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy.
Reynolds, Monica L; Oliverio, Andrea L; Zee, Jarcy; Hendren, Elizabeth M; O'Shaughnessy, Michelle M; Ayoub, Isabelle; Almaani, Salem; Vasylyeva, Tetyana L; Twombley, Katherine E; Wadhwani, Shikha; Steinke, Julia M; Rizk, Dana V; Waldman, Meryl; Helmuth, Margaret E; Avila-Casado, Carmen; Alachkar, Nada; Nester, Carla M; Derebail, Vimal K; Hladunewich, Michelle A; Mariani, Laura H.
Afiliação
  • Reynolds ML; Division of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Oliverio AL; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
  • Zee J; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Hendren EM; Division of Nephrology, Center for Glomerular Diseases, Columbia University Irving Medical Center, New York, New York, USA.
  • O'Shaughnessy MM; Department of Renal Medicine, Cork University Hospital, Wilton, Cork, Ireland.
  • Ayoub I; Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Almaani S; Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Vasylyeva TL; Division of Nephrology, Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
  • Twombley KE; Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Wadhwani S; Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Steinke JM; Division of Medical Subspecialties, Section of Pediatric Nephrology, Helen DeVos Children's Hospital, Grand Rapids, Michigan and Department of Pediatrics and Human Development, Michigan State University, Lansing, Michigan, USA.
  • Rizk DV; Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Waldman M; Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Helmuth ME; Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
  • Avila-Casado C; Department of Pathology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Alachkar N; Division of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Nester CM; Division of Nephrology, Departments of Internal Medicine and Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Derebail VK; Division of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Hladunewich MA; Divisions of Nephrology and Obstetrics, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.
  • Mariani LH; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Kidney Int Rep ; 8(4): 805-817, 2023 Apr.
Article em En | MEDLINE | ID: mdl-37069979
ABSTRACT

Introduction:

Preeclampsia increases the risk for future chronic kidney disease (CKD). Among those diagnosed with CKD, it is unclear whether a prior history of preeclampsia, or other complications in pregnancy, negatively impact kidney disease progression. In this longitudinal analysis, we assessed kidney disease progression among women with glomerular disease with and without a history of a complicated pregnancy.

Methods:

Adult women enrolled in the Cure Glomerulonephropathy study (CureGN) were classified based on a history of a complicated pregnancy (defined by presence of worsening kidney function, proteinuria, or blood pressure; or a diagnosis of preeclampsia, eclampsia, or hemolysis, elevated liver enzymes, and low platelets [HELLP] syndrome), pregnancy without these complications, or no pregnancy history at CureGN enrollment. Linear mixed models were used to assess estimated glomerular filtration rate (eGFR) trajectories and urine protein-to-creatinine ratios (UPCRs) from enrollment.

Results:

Over a median follow-up period of 36 months, the adjusted decline in eGFR was greater in women with a history of a complicated pregnancy compared to those with uncomplicated or no pregnancies (-1.96 [-2.67, -1.26] vs. -0.80 [-1.19, -0.42] and -0.64 [-1.17, -0.11] ml/min per 1.73 m2 per year, P = 0.007). Proteinuria did not differ significantly over time. Among those with a complicated pregnancy history, eGFR slope did not differ by timing of first complicated pregnancy relative to glomerular disease diagnosis.

Conclusions:

A history of complicated pregnancy was associated with greater eGFR decline in the years following glomerulonephropathy (GN) diagnosis. A detailed obstetric history may inform counseling regarding disease progression in women with glomerular disease. Continued research is necessary to better understand pathophysiologic mechanisms by which complicated pregnancies contribute to glomerular disease progression.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article